![]() Calcium oxalate crystals in breast biopsies. Vitamin E and evening primrose oil for management of cyclical mastalgia: A randomized pilot study. ![]() Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. P., Prencipe, M., Scintu, M., Apicella, A., Rossiello, R., Liguoro, G., Seripa, D., Gravina, C., Rabitti, C., Rinaldi, M., Nicol, T., Tommasi, S., Paradiso, A., Schittulli, F., Altomare, V., & Fazio, V. Journal of the National Cancer Institute, 61(4), 1055–1063. Relation between component parts of fibrocystic disease complex and breast cancer. An update on apocrine lesions of the breast. International Journal of Medicine and Medical Sciences, 2, 329–331. Comparison of tamoxifen with danazol in the management of fibrocystic disease. ![]() Breast dynamic contrast enhanced MRI: Fibrocystic changes presenting as a non-mass enhancement mimicking malignancy. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. G., Olson, N., Negassa, A., Duggan, C., & Ginsberg, M. Archives of Pathology & Laboratory Medicine, 110, 121. Is ‘fibrocystic disease’ of the breast precancerous? Consensus meeting, New York, October 1985. The New England Journal of Medicine, 353, 229–237. Benign breast disease and the risk of breast cancer. J., Johnson, J., Blake, C., Tlsty, T., Vachon, C. Expert Review of Molecular Diagnostics, 15, 1011–1022. Molecular and diagnostic features of apocrine breast lesions. International Journal of Clinical Practice, 54, 228–232. New England Journal of Medicine, 312, 146–151.įaiz, O., & Fentiman, I. Risk factors for breast cancer in women with proliferative breast disease. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 120, 249–252.ĭupont, W. Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy. ![]() Molecular pathology of breast apocrine carcinomas: A protein expression signature specific for benign apocrine metaplasia. Breast Cancer Research and Treatment, 149, 237–244.Ĭelis, J. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: A study from a population-based screening program. J., Baré, M., Vidal, C., Natal, C., Sánchez, M., Saladié, F., Ferrer, J., Vernet, M., Servitja, S., Rodríguez-Arana, A., Roman, M., Espinàs, J. Breast Cancer Research and Treatment, 37, 243–251.Ĭastells, X., Domingo, L., Corominas, J. Expression of the estrogen receptor gene in developing and adult human breast. Pathology Annual, 2, 93–111.īoyd, M., Hildebrandt, R. Fibrocystic disease: A continuing enigma. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |